Hong Kong, 16 November 2017 – Hong Kong Science and Technology Parks Corporation (“HKSTP”) and Guangzhou Institutes of Biomedicine and Health (“GIBH”) co-hosted the third Hong Kong and [...]
Valden Medical Hospital in Hawaii is selected following the other two hospitals in California, U.S. Geographical proximity makes it easier to supply clinical drugs manufactured in South Korea [...]
Two Hospitals in the U.S. have started recruiting patients SEOUL, South Korea – Biotechnology company Nature Cell Co., Ltd. (KOSDAQ: 007390) (Nature Cell) announced the recruitment of [...]
SEOUL, South Korea–R-Japan, an affiliated company of Nature Cell (KOSDAQ: 007390), announced the results of its business performance in 2016. In 2016 R-Japan cultured and supplied a total [...]
The stem cell treatment VASCOSTEM has been registered as the Orphan Drug in Development Phase. On February 10th, 2017 the Biostar Stem Cell Research Centre (CEO - Ra Jeong Chan), jointly run by [...]
Non-surgical intravascular administration is expected to improve stem cell therapeutic properties in treatments of incurable diseases. On January 25th Biostar Stem Cell Research Institute, headed [...]
The Biostar Stem Cell Research Centre (CEO: Ra Jeong Chan) run by Nature Cell and R-Bio announced that it has completed a registration process for an orphan drug in developmental phase for [...]
